GSK statement in response to the Prime Minister’s speech on life sciences
5 December 2011 | By GlaxoSmithKline
"The Government’s strategy for Life Sciences is a very important next step on the journey..."
List view / Grid view
5 December 2011 | By GlaxoSmithKline
"The Government’s strategy for Life Sciences is a very important next step on the journey..."
5 December 2011 | By Biogen Idec
Samsung and Biogen Idec announced that they have entered into an agreement to invest $300 million to establish a joint venture to develop, manufacture and market biosimilars...
5 December 2011 | By Novo Nordisk
New data from the A1chieve® study...
5 December 2011 | By AstraZeneca
A wide range of compounds will be made available FOC to UK medical researchers...
5 December 2011 | By Novartis
The European Commission has approved Galvus® (vildagliptin) (50 mg once a day) for the treatment of type 2 diabetes patients with moderate or severe renal impairment...
2 December 2011 | By Bristol-Myers Squibb Company
Phase II combination study in patients chronically infected with Hepatitis C...
2 December 2011 | By Pfizer
Pfizer Inc. have announced that it has completed its acquisition of Excaliard Pharmaceuticals, Inc., a privately owned biopharmaceutical company...
2 December 2011 | By Novartis
Novartis will showcase more than 160 presentations on data from its robust oncology portfolio...
1 December 2011 | By Boehringer Ingelheim
AVEO & Boehringer Ingelheim enter into an agreement...
1 December 2011 | By kdm communications limited
KNF Lab has launched the SC950 wireless vacuum pump system, combining fast and precise vacuum regulation with a flow rate of up to 50 l/min...
1 December 2011 | By Pfizer
Pfizer Inc. have announced that it has completed its previously announced acquisition of Ferrosan Consumer Health’s business...
1 December 2011 | By Roche
Roche have announced that the cobas EGFR Mutation Test is now CE marked...
Abbott announced today it has received clearance from the U.S. Food and Drug Administration for a fully-automated 25-OH Vitamin D assay performed on its widely used ARCHITECT® laboratory testing platform.
30 November 2011 | By Teva
A portion of the profits from Ranbaxy’s sales of Atorvastatin Calcium Tablets during Ranbaxy’s 180-day first-to-file exclusivity period, will be paid to Teva...
30 November 2011 | By Roche
Results from studies to be presented at SABCS...